Bibliographie

Bibliographie COVID et troubles cognitifs

1. Ardila, A., & Lahiri, D., (2020). Executive dysfunction in COVID-19 patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 1377-1378.

2. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Se-verity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.

3. Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, Raoult D. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):592-595. doi: 10.1007/s00259-020-04973-x.

4. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 382(23):2268–2270. https://doi.org/10.1056/NEJMc2008597.

5. Kocevska, D., Blanken, T. F., Van Someren, E.J.W., & Rosler, L. (2020). Sleep quality during the COVID-19 pandemic: not one size fits all. Sleep Medicine, 76, 86-88.

6. Kossigan Kokou-Kpolou, C., Megalakaki, O., Laimou, D., & Kousouri, M. (2020). Insomnia during COVID-19 pandemic and lockdown: prevalence, severuty and associated risk factors in french population. Psychiatry Research, 290, 113128.

7. Mahalakshmi AM, Ray B, Tuladhar S, Bhat A, Paneyala S, Patteswari D, Sakharkar MK, Hamdan H, Ojcius DM, Bolla SR, Essa MM, Chidambaram SB, Qoronfleh MW (2020) Does COVID‐19 contribute to development of neurological disease? Immun Inflamm Dis:iid3.387. https://doi.org/10.1002/iid3.387.

8. Mao et al., (2020). Neurologic Manifestations of Hospitalized Patients with coronavirus disease 2019 in Wuhan, China. Jama Neurology,77(6), 683-690.

9. Miners, s., Kehoe, P.G., & Love, S. (2020). Cognitive impact of COVID-19: looking beyong the short term. Alzheimer’s Research & Therapy, 12:170.

10. Mirfazeli, F. s., Sarabi-Jamab, A., Jahanbakshi, A., Kordi, A., Javadnia, P., Vahid Sharia, S., Aloosh, O., Almazi-Dooghaee, M., & Reza Faiz, S.H. (2020). Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories. Nature Research, 10:20-957

11. Moreno, C. et al., (2020). How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry, 7, 813-824.

12. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062

13. Morin CM. Insomnia: Psychological assessment and management. New York: Guilford Press; 1993.

14. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treat-ment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601. PMID: 21532953; PMCID: PMC3079939.

15. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT (2020) Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med 382(20):e60. https://doi.org/10.1056/NEJMc2009787

16. Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF (2020) Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 140(1):1–6. https://doi.org/10.1007/s00401-020-02166-2

17. Ritchie K, Chan D, Watermeyer T (2020) The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun 2(2):fcaa069. https://doi.org/10.1093/braincomms/fcaa069

18. Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y, Szigeti-Buck K, Yasumoto Y, Wang G, Castaldi C, Heltke J, Ng E, Wheeler J, Alfajaro MM, Levavasseur E, Fontes B, Ravindra NG, Van Dijk D, ManeS, Gunel M, Ring A, Jaffar Kazmi SA, Zhang K, Wilen CB, Horvath TL, Plu I, Haik S, Thomas JL, Louvi A, Farhadian SF, Huttner A, Seilhean D, Renier N, Bilguvar K, Iwasaki A. Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv 2020 Sep 8:2020.06.25.169946. doi: 10.1101/2020.06.25.169946.

19. Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart JL, Payan C, Coutellier A, Herson S, Baril L, Bricaire F, Calvez V, Cabanis EA, Lacomblez L, Lubetzki C. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology. 2001 Jan 9;56(1):112-5. doi: 10.1212/wnl.56.1.112. PMID: 11148248.

20. Suarez, S; Eynard B., Granon S. et al (2019). Method and system for testing cognition by processing a subject's response to stimuli. International PCT Application PCT/FR2020/051299.

21. Suarez SV, Stankoff B, Conquy L, Rosenblum O, Seilhean D, Arvanitakis Z, Lazarini F, Bricaire F, Lubetzki C, Hauw JJ, Dubois B (2000) Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. Eur J Neurol 7(2):151–158 .

22. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010 Jun 1;24(9):1243-50. doi: 10.1097/QAD.0b013e3283354a7b. PMID: 19996937.

23. Taquet, M., Geddes, J.R., Husain, M., Luciano, S., & Harrison, P.J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(21)00084-5

24. Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo MM, Gerloff C, Heesen C, Schulze Zur Wiesch J, Friese MA. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020 Nov 23;2(2):fcaa205. doi: 10.1093/braincomms/fcaa205. PMID: 33376990; PMCID: PMC7717144.

25. Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., et al., 2020. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang da xue xue bao Yi xue ban 1⁄4 J. Zhejiang. Univ. Med. Sci. 49, 147–157.

26. Zhou, H., Lu, S., Chen, J., Wei, N., Wang, D., Luy, H., Shi, c., & Hu, S. (2020). The landscape of cognitive function in recovered CODIV-19 patients. Journal of Psychiatric Reasearch, 129, 98-102.